Insider Transactions in Q2 2022 at Gelesis Holdings, Inc. (GLS)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 15
2022
|
Raju S Kucherlapati |
BUY
Open market or private purchase
|
Direct |
24,625
+21.43%
|
$24,625
$1.95 P/Share
|
|
Jun 08
2022
|
Elaine Chiquette Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
80,500
+23.43%
|
-
|
|
May 06
2022
|
Alison Bauerlein Director |
BUY
Grant, award, or other acquisition
|
Direct |
51,095
+50.0%
|
-
|
|
May 06
2022
|
Kathryn Cavanaugh Director |
BUY
Grant, award, or other acquisition
|
Direct |
48,814
+44.19%
|
-
|
|
May 06
2022
|
David Abraham General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
256,437
+48.84%
|
-
|
|
May 06
2022
|
Elaine Chiquette Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
182,579
+47.41%
|
-
|
|
May 06
2022
|
Clayton Christopher Director |
BUY
Grant, award, or other acquisition
|
Direct |
49,270
+8.8%
|
-
|
|
May 06
2022
|
Paul R. Fonteyne Director |
BUY
Grant, award, or other acquisition
|
Direct |
53,832
+50.0%
|
-
|
|
May 06
2022
|
Raju S Kucherlapati |
BUY
Grant, award, or other acquisition
|
Direct |
50,639
+43.55%
|
-
|
|
May 06
2022
|
Harry L. Leider Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
314,090
+46.58%
|
-
|
|
May 06
2022
|
Elliot Maltz Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
431,975
+48.02%
|
-
|
|
May 06
2022
|
David A. Pass Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
483,219
+46.9%
|
-
|
|
May 06
2022
|
Dominic Perks Director |
BUY
Grant, award, or other acquisition
|
Direct |
49,270
+50.0%
|
-
|
|
May 06
2022
|
Alessandro Sannino Lead Project Scientist |
BUY
Grant, award, or other acquisition
|
Direct |
68,966
+24.98%
|
-
|
|
May 06
2022
|
Jane Wildman Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,182
+50.0%
|
-
|
|
May 06
2022
|
Yishai Zohar President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
960,893
+13.23%
|
-
|